ATP8B2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.925400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.772400E-01
Normal-vs-Stage2
2.387000E-01
Normal-vs-Stage3
1.302240E-01
Normal-vs-Stage4
8.812000E-01
Stage1-vs-Stage2
3.977200E-01
Stage1-vs-Stage3
4.050800E-01
Stage1-vs-Stage4
8.130400E-01
Stage2-vs-Stage3
6.652000E-01
Stage2-vs-Stage4
2.812800E-01
Stage3-vs-Stage4
3.309600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.908600E-01
Normal-vs-AfricanAmerican
7.937000E-01
Normal-vs-Asian
8.582400E-02
Caucasian-vs-AfricanAmerican
4.063400E-01
Caucasian-vs-Asian
2.060200E-01
AfricanAmerican-vs-Asian
2.126200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.210800E-01
Normal-vs-Female
4.092200E-01
Male-vs-Female
1.790980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.885000E-01
Normal-vs-Age(41-60Yrs)
5.275200E-01
Normal-vs-Age(61-80Yrs)
2.336800E-01
Normal-vs-Age(81-100Yrs)
2.888000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.479400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.462400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.722100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.240400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.570400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.727400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.483790E-01
Normal-vs-Daily Drinker
3.531700E-02
Normal-vs-Weekly Drinker
5.254200E-01
Normal-vs-Occasional Drinker
1.337160E-01
Normal-vs-Social Drinker
7.342000E-01
Non Drinker-vs-Daily Drinker
7.431200E-01
Non Drinker-vs-Weekly Drinker
1.207800E-01
Non Drinker-vs-Occasional Drinker
5.117600E-01
Non Drinker-vs-Social Drinker
9.289600E-02
Daily Drinker-vs-Weekly Drinker
3.934300E-02
Daily Drinker-vs-Occasional Drinker
2.548800E-01
Daily Drinker-vs-Social Drinker
7.767600E-02
Weekly Drinker-vs-Occasional Drinker
2.763000E-01
Weekly Drinker-vs-Social Drinker
8.112200E-01
Occasional Drinker-vs-Social Drinker
2.714600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.114800E-01
Normal-vs-Grade 2
5.340800E-01
Normal-vs-Grade 3
7.222000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.566600E-01
Grade 1-vs-Grade 3
1.343200E-01
Grade 1-vs-Grade 4
5.114800E-01
Grade 2-vs-Grade 3
9.586500E-02
Grade 2-vs-Grade 4
5.340800E-01
Grade 3-vs-Grade 4
7.222000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.700400E-01
Normal-vs-NonDiabetic
2.311200E-01
Diabetic-vs-NonDiabetic
7.982800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.889800E-02
Normal-vs-NoPancreatitis
2.901800E-01
Pancreatitis-vs-NoPancreatitis
3.074400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.445000E-01
Normal-vs-N1
2.486600E-01
N0-vs-N1
8.492400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.836400E-02
Normal-vs-TP53-NonMutant
6.043000E-01
TP53-Mutant-vs-TP53-NonMutant
2.027800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
